Alpha Tau Medical (DRTS) Interest Expenses (2020 - 2026)
Alpha Tau Medical (DRTS) posted Interest Expenses of $22.6 million for Q4 2025, up 131.84% sequentially from $9.8 million in Q2 2025, and up 217.17% YoY from $7.1 million in Q4 2024.
Alpha Tau Medical (DRTS) Interest Expenses (2020 - 2026) Analysis & Trends
Alpha Tau Medical has reported Interest Expenses for 6 years, with the latest figure at $22.6 million in Q4 2025.
- Quarterly Interest Expenses rose 217.17% year-over-year to $22.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $22.6 million (up 217.17% YoY) and the FY2025 annual result came in at $22.6 million, up 137.51% from the prior year.
- Interest Expenses improved to $22.6 million in Q4 2025 per DRTS's latest filing, from $9.8 million in the prior quarter.
- Over five years, Interest Expenses peaked at $22.6 million in Q4 2025 and troughed at $4000.0 in Q1 2021.
- A 5-year average of $6.3 million and a median of $5.6 million in 2023 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2021 and 2023: Interest Expenses tumbled 99.6% in 2021, then soared 39628.57% in 2023.
- Over 5 years, Interest Expenses stood at $3.8 million in 2021, then surged by 33.68% to $5.1 million in 2022, then gained by 14.81% to $5.8 million in 2023, then gained by 22.24% to $7.1 million in 2024, then surged by 217.17% to $22.6 million in 2025.
- According to Business Quant data, Interest Expenses over the past three periods registered $22.6 million, $9.8 million, and $7.1 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Alpha Tau Medical | 1.32 Bn | 1.32 Bn | - | 133.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 133.76 Mn |
| Jun 30, 2026 | 133.76 Mn |
| Dec 31, 2025 | 22.63 Mn |
| Dec 31, 2025 | 22.63 Mn |
| Jun 30, 2025 | 9.76 Mn |
| Jun 30, 2025 | 9.76 Mn |
| Dec 31, 2024 | 7.14 Mn |
| Dec 31, 2024 | 7.14 Mn |
| Jun 30, 2024 | 9.86 Mn |
| Jun 30, 2024 | 9.86 Mn |
| Dec 31, 2023 | 5.84 Mn |
| Dec 31, 2023 | 5.84 Mn |
| Jun 30, 2023 | 5.56 Mn |
| Jun 30, 2023 | 5.56 Mn |
| Dec 31, 2022 | 5.08 Mn |
| Dec 31, 2022 | 5.08 Mn |
| Jun 30, 2022 | 14,000.00 |
| Jun 30, 2022 | 14,000.00 |
| Mar 31, 2022 | 36,000.00 |
| Mar 31, 2022 | 36,000.00 |